These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21451853)

  • 41. Self-assembled silk sericin/poloxamer nanoparticles as nanocarriers of hydrophobic and hydrophilic drugs for targeted delivery.
    Mandal BB; Kundu SC
    Nanotechnology; 2009 Sep; 20(35):355101. PubMed ID: 19671963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of molecular weight on the oleoyl-chitosan nanoparticles as carriers for doxorubicin.
    Zhang J; Chen XG; Sun GZ; Huang L; Cheng XJ
    Colloids Surf B Biointerfaces; 2010 Jun; 77(2):125-30. PubMed ID: 20172698
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cancer-cell-specific induction of apoptosis using mesoporous silica nanoparticles as drug-delivery vectors.
    Rosenholm JM; Peuhu E; Bate-Eya LT; Eriksson JE; Sahlgren C; Lindén M
    Small; 2010 Jun; 6(11):1234-41. PubMed ID: 20486218
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimization of epirubicin nanoparticles using experimental design for enhanced intravesical drug delivery.
    Chang LC; Wu SC; Tsai JW; Yu TJ; Tsai TR
    Int J Pharm; 2009 Jul; 376(1-2):195-203. PubMed ID: 19439169
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enzyme-responsive intracellular controlled release using nanometric silica mesoporous supports capped with "saccharides".
    Bernardos A; Mondragon L; Aznar E; Marcos MD; Martinez-Mañez R; Sancenon F; Soto J; Barat JM; Perez-Paya E; Guillem C; Amoros P
    ACS Nano; 2010 Nov; 4(11):6353-68. PubMed ID: 20958020
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis, self-assembly, and in vitro doxorubicin release behavior of dendron-like/linear/dendron-like poly(epsilon-caprolactone)-b-poly(ethylene glycol)-b-poly(epsilon-caprolactone) triblock copolymers.
    Yang Y; Hua C; Dong CM
    Biomacromolecules; 2009 Aug; 10(8):2310-8. PubMed ID: 19618927
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Furan-functionalized co-polymers for targeted drug delivery: characterization, self-assembly and drug encapsulation.
    Shi M; Shoichet MS
    J Biomater Sci Polym Ed; 2008; 19(9):1143-57. PubMed ID: 18727857
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Photoactive hybrid nanomaterials: indocyanine immobilized in mesoporous MCM-41 for "in-cell" bioimaging.
    Gianotti E; Bertolino CA; Benzi C; Nicotra G; Caputo G; Castino R; Isidoro C; Coluccia S
    ACS Appl Mater Interfaces; 2009 Mar; 1(3):678-87. PubMed ID: 20355990
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
    Wong HL; Bendayan R; Rauth AM; Wu XY
    J Control Release; 2006 Dec; 116(3):275-84. PubMed ID: 17097178
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting.
    Tseng CL; Wang TW; Dong GC; Yueh-Hsiu Wu S; Young TH; Shieh MJ; Lou PJ; Lin FH
    Biomaterials; 2007 Sep; 28(27):3996-4005. PubMed ID: 17570484
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reversion of multidrug resistance by tumor targeted delivery of antisense oligodeoxynucleotides in hydroxypropyl-chitosan nanoparticles.
    Wang J; Tao X; Zhang Y; Wei D; Ren Y
    Biomaterials; 2010 May; 31(15):4426-33. PubMed ID: 20188412
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Uniform mesoporous carbon as a carrier for poorly water soluble drug and its cytotoxicity study.
    Zhao P; Wang L; Sun C; Jiang T; Zhang J; Zhang Q; Sun J; Deng Y; Wang S
    Eur J Pharm Biopharm; 2012 Apr; 80(3):535-43. PubMed ID: 22193360
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel hyaluronic acid (HA) coated drug carriers (HCDCs) for human breast cancer treatment.
    Hyung W; Ko H; Park J; Lim E; Park SB; Park YJ; Yoon HG; Suh JS; Haam S; Huh YM
    Biotechnol Bioeng; 2008 Feb; 99(2):442-54. PubMed ID: 17625788
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and characterization of amphiphilic glycidol-chitosan-deoxycholic acid nanoparticles as a drug carrier for doxorubicin.
    Zhou H; Yu W; Guo X; Liu X; Li N; Zhang Y; Ma X
    Biomacromolecules; 2010 Dec; 11(12):3480-6. PubMed ID: 21028798
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structure-directing agents for the synthesis of TiO(2) -based drug-delivery systems.
    Ghedini E; Nichele V; Signoretto M; Cerrato G
    Chemistry; 2012 Aug; 18(34):10653-60. PubMed ID: 22767402
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mesoporous calcium silicate for controlled release of bovine serum albumin protein.
    Xue W; Bandyopadhyay A; Bose S
    Acta Biomater; 2009 Jun; 5(5):1686-96. PubMed ID: 19249262
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation.
    Tseng CL; Su WY; Yen KC; Yang KC; Lin FH
    Biomaterials; 2009 Jul; 30(20):3476-85. PubMed ID: 19345990
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.
    Oyarzun-Ampuero FA; Brea J; Loza MI; Torres D; Alonso MJ
    Int J Pharm; 2009 Nov; 381(2):122-9. PubMed ID: 19467809
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tumor-specific hybrid polyhydroxybutyrate nanoparticle: surface modification of nanoparticle by enzymatically synthesized functional block copolymer.
    Lee J; Jung SG; Park CS; Kim HY; Batt CA; Kim YR
    Bioorg Med Chem Lett; 2011 May; 21(10):2941-4. PubMed ID: 21489794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Controlled release using mesoporous materials containing gate-like scaffoldings.
    Aznar E; Martínez-Máñez R; Sancenón F
    Expert Opin Drug Deliv; 2009 Jun; 6(6):643-55. PubMed ID: 19519290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.